OriginClear (OCLN) 10-Q 21 Nov 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 16, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	ORIGINCLEAR, INC.
Entity Central Index Key	1,419,793
Trading Symbol	OCLN
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		1,410,006,088

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Dec. 31, 2017
CURRENT ASSETS
Cash	$ 899,687	$ 439,822
Contracts receivable, less allowance for doubtful accounts of $6,996 and $6,996 respectively	384,937	490,441
Convertible note receivable	82,883
Inventory	13,737	13,614
Prepaid expenses and other assets	34,086	61,607
Contract assets	36,761	88,589
Work in progress	84,157	84,157
TOTAL CURRENT ASSETS	1,536,248	1,178,230
NET PROPERTY AND EQUIPMENT	167,161	150,628
OTHER ASSETS
Fair value investment-securities	16,400
Other asset	19,538	19,538
Trademark	4,467	4,467
Security deposit	3,500	3,500
TOTAL OTHER ASSETS	43,905	27,505
TOTAL ASSETS	1,747,314	1,356,363
Current Liabilities
Accounts payable and other payable	676,391	827,656
Accrued expenses	1,109,505	932,092
Cumulative preferred stock dividends payable	1,976
Contract liabilities	250,184	154,048
Capital lease, current portion	9,088
Customer deposit	113,950	113,950
Warrant reserve	20,000	20,000
Deferred income	65,000	15,500
Loans payable, truck		11,090
Loan Payable, merchant cash advances, net of finance fees of $378,775 and $0, respectively	698,771
Loans payable, related party	235,243
Promissory note, current portion	93
Derivative liabilities	6,158,447	5,531,183
Convertible promissory notes, net of discount of $321,292 and $591,835, respectively	968,438	766,931
Total Current Liabilities	10,307,086	8,372,450
Long Term Liabilities
Capital lease, long term portion	29,190
Promissory note, long term portion	74,902
Loan payable, long term portion		4,609
Convertible promissory notes	2,754,124	2,811,000
Total Long Term Liabilities	2,858,216	2,815,609
Total Liabilities	13,165,302	11,188,059
Series F 8% Convertible Preferred Stock, redeemable value of $750,000 and $0, respectively	750,000
COMMITMENTS AND CONTINGENCIES (See Note 12)
SHAREHOLDERS' DEFICIT
Common stock, $0.0001 par value, 8,000,000,000 shares authorized 690,853,446 and 112,888,964 equity shares issued and outstanding, respectively	69,086	11,289
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Additional paid in capital	61,544,104	58,618,560
Accumulated other comprehensive loss	(134)	(134)
Accumulated deficit	(73,784,139)	(68,461,412)
TOTAL SHAREHOLDERS' DEFICIT	(12,167,988)	(9,831,696)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	1,747,314	1,356,363
Series B Preferred stock
SHAREHOLDERS' DEFICIT
Preferred stock value	1	1
Series C Preferred stock
SHAREHOLDERS' DEFICIT
Preferred stock value
Series E Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value	3,094
Series F Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value
Series D-1 Preferred Stock
SHAREHOLDERS' DEFICIT
Preferred stock value

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Allowance for doubtful accounts	$ 6,996	$ 6,996
Net of discount current	321,775	591,835
Merchant cash advances, net of finance fees	$ 378,775	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	8,000,000,000	8,000,000,000
Common stock, shares issued	690,853,446	112,888,964
Common stock, shares outstanding	690,853,446	112,888,964
Preferred treasury stock, shares outstanding	1,000	1,000
Convertible preferred stock, redeemable value	$ 750,000
Series B Preferred stock
Preferred stock, shares issued	3,333	3,333
Preferred stock, shares outstanding	3,333	3,333
Series C Preferred stock
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series E Preferred Stock
Preferred stock, shares issued	2,440,871	2,440,871
Preferred stock, shares outstanding	2,440,871	2,440,871
Series D-1 Preferred Stock
Preferred stock, shares issued	28,500,000	28,500,000
Preferred stock, shares outstanding	28,500,000	28,500,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Sales	$ 1,094,118	$ 1,112,438	$ 3,678,261	$ 2,294,891
Cost of Goods Sold	754,214	949,657	2,766,244	2,031,334
Gross Profit	339,904	162,781	912,017	263,557
Operating Expenses
Selling and marketing expenses	470,926	539,975	1,336,512	2,165,213
General and administrative expenses	771,944	830,444	2,143,859	1,842,815
Research and development	49,880	53,939	167,944	136,582
Depreciation and amortization expense	14,739	12,961	43,857	39,506
Total Operating Expenses	1,307,489	1,437,319	3,692,172	4,184,116
Loss from Operations	(967,585)	(1,274,538)	(2,780,155)	(3,920,559)
OTHER INCOME (EXPENSE)
Other income	2,017		32,883
Unrealized gain on investment securities	200		(13,600)
Realized loss on investment	(20,000)		(20,000)
Gain on sale of asset			(406)
Commitment fees	(41,498)	(736,052)	(425,824)	(1,409,655)
Loss on conversion of debt at fair value	(597,090)	(59,936)	(860,880)	(760,758)
Gain/(Loss) on net change in derivative liability	7,680,163	(2,633,663)	(60,952)	(2,026,380)
Interest expense	(737,319)	(173,448)	(1,193,793)	(542,450)
TOTAL OTHER INCOME (EXPENSE)	6,286,473	(3,603,099)	(2,542,572)	(4,739,243)
NET INCOME (LOSS)	5,318,888	(4,877,637)	(5,322,727)	(8,659,802)
PREFERRED STOCK DIVIDENDS	(1,976)		(1,976)
NET INCOME (LOSS) AVAILABLE TO SHAREHOLDERS	$ 5,316,912		$ (5,324,703)
BASIC AND DILUTED EARNINGS (LOSS) PER SHARE	$ 0.021	$ (0.09)	$ (0.031)	$ (0.222)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED	252,473,213	54,334,415	173,594,567	38,977,842

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Shareholders' Deficit - 9 months ended Sep. 30, 2018 - USD ($)	Total	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive loss	Accumulated Deficit
Beginning balance at Dec. 31, 2017	$ (9,831,696)	$ 1	$ 11,289	$ 58,618,560	$ (134)	$ (68,461,412)
Beginning balance, shares at Dec. 31, 2017		4,333	112,888,964
Common stock issuance for conversion of debt and accrued interest	1,448,262		$ 29,298	1,418,964
Common stock issuance for conversion of debt and accrued interest, shares			292,974,292
Common stock issued at fair value for services	994,689		$ 11,772	982,917
Common stock issued at fair value for services, shares			117,724,284
Common stock issued thru a private placement for purchase of Series F Preferred stock			$ 16,727	(16,727)
Common stock issued thru a private placement for purchase of Series F Preferred stock, shares			167,265,906
Series D Preferred stock issued through a private placement	280,000	$ 1,581		278,419
Series D Preferred stock issued through a private placement, shares		15,805,554
Series D Preferred stock converted to Series E Preferred stock	(280,000)	$ (1,581)		(278,419)
Series D Preferred stock converted to Series E Preferred stock, shares		(15,805,554)
Series D-1 Preferred stock issued for services		$ 2,850		(2,850)
Series D-1 Preferred stock issued for services, shares		28,500,000
Series E Preferred stock issued thru a private placement	507,098	$ 244		506,854
Series E Preferred stock issued thru a private placement, shares		2,440,871
Stock option compensation cost	38,362			38,362
Cumulative preferred stock dividend	(1,976)			(1,976)
Net loss	(5,322,727)					(5,322,727)
Ending balance at Sep. 30, 2018	$ (12,167,988)	$ 3,095	$ 69,086	$ 61,544,104	$ (134)	$ (73,784,139)
Ending balance, shares at Sep. 30, 2018		30,945,204	690,853,446

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (5,322,727)	$ (8,659,802)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	43,857	39,506
Common stock and warrants issued for services	994,689	3,418,598
Stock option and warrant compensation expense	38,362	71,603
(Gain)/Loss on net change in valuation of derivative liability	60,952	2,026,380
Loss on conversion of debt	860,880	760,758
Debt discount recognized as interest expense	483,577	313,546
Loss on sale of asset	406
Net unrealized loss on fair value of security	13,600
Realized loss on security investment	20,000
Exchange of investment for services	80,000
Amortization of financing cost	246,035
Change in Assets (Increase) Decrease in:
Contracts receivable	75,504	(140,653)
Prepaid expenses	27,521	24,137
Contract assets	51,828	38,374
Inventory asset	(123)	(13,614)
Work in progress		1,928
Change in Liabilities Increase (Decrease) in:
Accounts payable	(151,264)	468,406
Accrued expenses	320,235	121,047
Contract liabilities	96,136	209,294
Deferred income	49,500	24,100
NET CASH USED IN OPERATING ACTIVITIES	(2,011,034)	(1,296,392)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Fair value investment - security	(100,000)
Convertible note receivable	(80,000)
Proceeds from sale of asset	2,000
Purchase of fixed assets	(17,357)	(33,845)
CASH USED IN INVESTING ACTIVITIES	(195,357)	(33,845)
CASH FLOWS FROM FINANCING ACTIVITIES:
Loan payable, truck	(15,699)	23,372
Payments on capital lease	(7,162)
Loans payable, financing	1,366,246
Payments made on financing loans	(987,471)
Loan payable, related party	248,870
Payments made on related party loans	(13,626)
Promissory note payable	67,500
Proceeds from convertible promissory notes	750,500
Proceeds for issuance of common stock for cash	1,257,098	1,297,750
NET CASH PROVIDED BY FINANCING ACTIVITIES	2,666,256	1,321,122
Foreign currency effect on cash flow		(42)
NET DECREASE IN CASH	459,865	(9,157)
CASH BEGINNING OF PERIOD	439,822	351,321
CASH END OF PERIOD	899,687	342,164
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	212,284	1,823
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt and accrued interest	1,448,262	1,234,972
Common stock issued at fair value on settlement of accounts payable		117,931
Common stock issued at fair value for supplemental shares	424,245	1,409,655
Capitalized lease asset	$ 45,440

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2018
Basis of Presentation [Abstract]
BASIS OF PRESENTATION	1. The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) (formerly OriginOil, Inc.) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ending December 31, 2018. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2017. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed consolidated financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company’s revenue is not yet sufficient to cover its operating expenditures and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. Management believes the existing shareholders, the prospective new investors, current and future sales will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	9 Months Ended
	Sep. 30, 2018
Summary of Significant Accounting Polices [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technology Limited. All material intercompany transactions have been eliminated upon consolidation of these entities. Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company has excluded 3,609,143 stock options, 261,149,413 warrants, convertible debt of $3,494,546 and shares issuable from convertible preferred stock for the nine months ended September 30, 2018, because their impact on the loss per share is anti-dilutive. The Company did include convertible debt of $549,308 in its diluted earnings per share, because their impact on the earnings per share is dilutive. The Company has excluded 3,697,495 of stock options, 474,335 warrants, and the shares issuable from convertible debt of $3,667,068 and shares issuable from convertible preferred stock for the nine months ended September 30, 2018, because their impact on the loss per share is anti-dilutive. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, debt beneficial conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $6,996 as of September 30, 2018 and December 31, 2017, respectively. The net contract receivable balance was $384,937 and $490,441 at September 30, 2018 and December 31, 2017, respectively. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2018, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets and liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, 2018. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 16,400 $ - $ - $ 16,400 Total Assets measured at fair value $ 16,400 $ - $ - $ 16,400 The following is a reconciliation of the fair value securities for which level 3 inputs were used in determining the approximate fair value: Balance as of May 17, 2018 $ 130,000 Investment exchanged for services (80,000 ) Net realized loss on asset (20,000 ) Net unrealized loss on asset (13,600 ) Balance as of September 30, 2018 $ 16,400 Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 6,158,447 $ - $ - $ 6,158,447 Total liabilities measured at fair value $ 6,158,447 $ - $ - $ 6,158,447 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2018 $ 5,531,183 Fair Value of derivative liabilities issued 566,312 Loss on change in derivative liability 60,952 Balance as of September 30, 2018 $ 6,158,447 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 9/30/2018 Risk free interest rate 2.15% - 2.94% Stock volatility factor 131.0% - 241.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-2, which creates ASC Topic 842, “Leases.” This update increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company is currently evaluating the impact of the adoption of ASU 2017-12 on the Company’s financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (ASC 606), to clarify the principles of recognizing revenue and create common revenue recognition guidance between U.S. GAAP and International Financial Reporting Standards. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services and is recognized at an amount that reflects the consideration expected to be received in exchange for such goods or services. In addition, ASC 606 requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The ASC is effective for fiscal years beginning after December 15, 2017. The Company has adopted ASC 606 beginning on January 1, 2018. The adoption of ASC 606 did not have a significant impact on the Company’s revenue recognition policies. See Note 7 for additional disclosures in accordance with the new revenue recognition standard. The Company adopted ASU 2016-01, “Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company’s financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	9 Months Ended
	Sep. 30, 2018
Capital Stock [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock As of April 11, 2018, the Board of Directors authorized an increase in shares of preferred stock, par value $0.0001 per share to 550,000,000 shares from 750,000 shares. The Board adopted a Certificate of Designation establishing the rights, preferences, privileges and other terms of Series D preferred stock and Series D-1 preferred stock, par value $0.0001 per share. The Board authorized and approved 400,000,000 shares of Series D and 50,000,000 shares of Series D-1 preferred stock. Series B On October 1, 2015, the Company filed a Certificate of Designation for Series B preferred stock with the Secretary of State of Nevada and the shares of Series B preferred stock were issued to the shareholders of Progressive Water Treatment, Inc. in connection with the share exchange agreement. One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B preferred stock was issued (the “Original Issue Date); one third (1/3) may be converted beginning two (2) years after the Original Issue Date; and the remaining one third (1/3) may be converted beginning three years after the Original Issue Date. The number of shares of common stock issuable for each share of converted Series B preferred stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice. On August 12, 2016, the agreement was amended to include make-good-shares. The conversion price set forth in Section 1.2 of the agreement shall be adjusted to reflect the lower of $1.05 or the price of the Company’s common stock calculated using the average closing prices of the Company’s common stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $0.35 per share, the adjusted conversion price shall be $0.35 per share. See Note 3. The conversion price is subject to adjustment in the case of reverse splits, stock dividends, reclassifications and the like. In addition, the conversion price is subject to certain full ratchet anti-dilution protection. Accordingly, the preferred stock is valued under the provision of ASC Topic 815, Derivatives and Hedging, because the conversion feature of the preferred stock was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The Series B preferred stock shall have the rights, preferences and privileges as set forth in the exchange agreement. As of September 30, 2018, there are 3,333 shares of Series B preferred stock outstanding. Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of September 30, 2018, there are 1,000 shares of Series C preferred stock outstanding. Series D On April 13, 2018, the Board adopted resolutions creating a series of shares of convertible preferred stock designated as 0% Series D preferred stock (the “Series D preferred stock”) with a par value of $0.0001. The shares of Series D preferred stock do not have a dividend rate or liquidation preference and do not carry any voting rights. The purchase price shall be $0.02 per unit for an aggregate investment amount of less than $50,000; $0.018 for an aggregate amount of $50,000 or greater, but less than $100,000; $0.016 for an aggregate amount of $100,000 or greater, but less than $250,000; $0.014 for an aggregate amount of $250,000 or greater. At no time may all or a portion of the Series D preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of June 30, 2018, the Company issued 15,805,554 shares of Series D preferred stock through a private placement for a cash value of $280,000 at prices ranging $0.016 to $0.020. During the period ended September 30, 2018, the Series D shares were exchanged for Series E preferred stock. As of September 30, 2018, there were no outstanding Series D preferred stock. Series D-1 On April 13, 2018, the Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the “Series D-1 preferred stock”) with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock have a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible into one share of common stock. The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. The Company issued 28,500,000 preferred shares for services. As of September 30, 2018, there were 28,500,000 shares issued and outstanding. Series E On August 14, 2018, the Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the “Series E preferred stock”) with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock, accompanied with one hundred (100) warrants each for the purchase of one (1) share of common stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock is convertible into one share of common stock. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of September 30, 2018, there were 2,440,871 shares issued and outstanding. Series F On August 14, 2018, the Company filed a Certificate of Designation for its Series F Convertible preferred stock (the “Series F preferred stock”) with the Secretary of State of Nevada designating $2,000,000 units, with each unit consisting of 100 shares of the Company’s Series F preferred stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F preferred stock do not have a liquidation preference. Each share of Series F preferred stock is convertible into one share of common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. At no time may all or a portion of the Series F preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of September 30, 2018, the Company accrued dividends in the amount of $1,976, and has 750 shares issued and outstanding. Common Stock On August 9, 2018, the Company and Board of Directors increased the aggregate number of authorized shares of common stock of the Corporation to 8,000,000,000 shares from 2,000,000,000 shares. Nine months ended September 30, 2018 The Company issued 292,974,292 shares of common stock for the settlement of convertible promissory notes in an aggregate principal in the amount of $524,714, plus interest in the amount of $62,668, with an aggregate fair value loss on conversion of debt in the amount of $860,880, based upon conversion prices of $0.0019 to $0.0329. The Company issued 117,724,284 shares of common stock for services at fair value of $994,689. The Company issued 167,265,906 shares of common stock through a private placement for purchase of Series F preferred stock.

Convertible Promissory Notes

Convertible Promissory Notes	9 Months Ended
	Sep. 30, 2018
Convertible Promissory Notes [Abstract]
CONVERTIBLE PROMISSORY NOTES	4. CONVERTIBLE PROMISSORY NOTES As of September 30, 2018, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes, net of debt discount $ 3,722,562 Less current portion 968,438 Total long-term liabilities $ 2,754,124 Maturities of long-term debt for the next five years are as follows: Period Ending September 30, Amount 2020 2,245,000 2021 325,000 2022 - 2023 184,124 $ 2,754,124 At September 30, 2018, the $4,043,854 in convertible promissory notes has a remaining debt discount of $321,292, leaving a net balance of $3,722,562. On various dates through May, 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per annum. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $2.10 to $4.90 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the nine months ended September 30, 2018, the Company issued 50,762,187 shares of common stock, upon conversion of $121,600 in principal, plus accrued interest of $44,064, with a fair value loss on settlement of $328,540. As of September 30, 2018, the 2014-2015 Notes had an aggregate remaining balance of $1,364,400. As of September 30, 2018, the unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining principal balance of $184,124, plus accrued interest of $13,334 were amended. The OID Notes included an original issue discount and one time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, and were extended through September 30, 2018. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $15.31. After the amendment, the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. As of September 30, 2018, the remaining balance on the note was $184,124. The Company issued various, unsecured convertible promissory notes (the “2015-2016 Notes”), on various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per annum. The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $0.70 to $2.80 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. The remaining balance of the 2015-2016 Notes as of September 30, 2018, was $1,325,000. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for an accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of September 30, 2018, the remaining balance on the Dec 2015 Note was $167,048. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for an accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. On September 15, 2016, the Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the time it was entered into, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $140,543 during the nine months ended September 30, 2018. As of September 30, 2018, the remaining balance on the Sep 2016 Note was $430,896. The Company issued an unsecured convertible promissory note (the “Dec 20 Note”), in the amount of $150,000 on December 20, 2017. The Dec 20 Note matures on December 20, 2018. The Dec 20 Note bears interest at 10% per annum. The Dec 20 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.05 per share or 50% of the lowest trade price during the twenty trading days immediately before the conversion. The conversion feature of the Dec 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Dec 20 Note. During the nine months ended the Company issued 72,963,066 shares of common stock, upon conversion of principal in the amount of $123,500, plus accrued interest of $8,033, with a fair value loss on settlement of $197,877.The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $33,603 during the nine months ended September 30, 2018. As of September 30, 2018, the remaining balance on the note was $26,500. The Company issued an unsecured convertible promissory note (the “Dec 22 Note”), in the amount of $75,000 on December 22, 2017. The Dec 22 Note matures on December 22, 2018. The Dec 22 Note bears interest at 10% per annum. The Dec 22 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of $0.05 per share or 50% of the lowest trade price during the twenty trading days upon default of the prepayment date. The conversion feature of the Dec 22 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Dec 22 Note. During the nine months ended the Company issued 40,129,653 shares of common stock, upon conversion of principal in the amount of $69,864, with a fair value loss on settlement of $80,509. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $6,450 during the nine months ended September 30, 2018. As of September 30, 2018, the remaining balance on the note was $5,136. The Company issued various unsecured convertible promissory notes (the “Jan-Aug 2018 Notes”), in the aggregate amount of $293,000 on various dates from January 24, 2018 thru August 28, 2018. The Jan-Aug 2018 Notes matures on dates from January 24, 2018 thru August 28, 2019. The Jan-Aug 2018 Notes bear interest at 10% per annum. The Jan-Aug 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion. The conversion feature of the Jan-Aug 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan-Aug 2018 Notes. During the nine months ended the Company issued 97,506,179 shares of common stock, upon conversion of principal in the amount of $174,000, plus accrued interest of $ 8,700, with a fair value loss on settlement of $175,027. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $201,834 during the nine months ended September 30, 2018. As of September 30, 2018, the balance remaining on the Jan-Aug 2018 Notes was $119,000. The Company issued (2) unsecured convertible promissory notes (the “Feb 2018 Notes”), in the aggregate principal amount of $157,500 (each in the amount of $78,750) on February 23, 2018. The Feb 2018 Notes matures on February 23, 2019, and bear interest at 10% per annum. The first of the two Feb 2018 Notes shall be paid for by the Buyer. The second of the two Feb 2018 Notes shall initially be paid for by the issuance of an offsetting $78,750 secured note issued to the Company by the Buyer. The first of the two notes was funded with cash and the Company must agree to the funding of the second of the two Feb 2018 Notes, before it can be funded with cash. The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company’s common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion. The conversion feature of the Feb 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2018 Notes. During the nine months ended September 30, 2018, the Company issued 31,613,207 shares of common stock, upon conversion of principal in the amount of $35,750, plus accrued interest of $1,872, with a fair value loss on settlement of $78,927. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $34,065 during the nine months ended September 30, 2018. As of September 30, 2018, the balance remaining on the Feb 2018 Notes was $121,750. The Company issued various unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on various dates of April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes matures on dates of April 2, 2019 and May 31, 2019. The Apr & May 2018 Notes bear interest at 10% per annum. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $67,082 during the nine months ended September 30, 2018. As of September 30, 2018, the remaining balance on the Apr & May 2018 Notes were $300,000. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of September 30, 2018 was $6,158,447.

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Sep. 30, 2018
Derivative Liabilities [Abstract]
DERIVATIVE LIABILITIES	5. DERIVATIVE LIABILITIES We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations. The convertible notes issued and described in Note 4 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the nine months ended September 30, 2018, as a result of the convertible notes (“Notes”) issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $566,312, based upon a Binomial-Model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes. During the nine months ended September 30, 2018, the Company converted $524,714 in principal of convertible promissory notes, plus accrued interest of $62,668. As a result of the conversion of these notes and the change in fair value of the remaining notes, the Company recorded a loss on conversion of debt in the amount of $860,880 in the statement of operations for the nine months ended September 30, 2018. At September 30, 2018, the fair value of the derivative liability was $6,158,447. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice valuation model. The significant assumptions used in the Binomial lattice valuation model for the derivative are as follows: 9/30/2018 Risk free interest rate 2.15% - 2.94% Stock volatility factor 131.0% - 241.0.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None

Options and Warrants

Options and Warrants	9 Months Ended
	Sep. 30, 2018
Options and Warrants [Abstract]
OPTIONS AND WARRANTS	6. OPTIONS AND WARRANTS Options The Board of Directors adopted Equity Incentive Stock Option Plans for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of options for 3,614,285 shares of common stock. The Options granted under these plans may be either incentive options or nonqualified options and shall be administered by the Company’s Board of Directors. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. Notwithstanding any other provision of the Plans or of any option agreement, each option shall expire on the date specified in the option agreement, which date shall not be later than the fifth (5th) anniversary from the effective date of grant. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective option agreements may provide. The stock options mature on July 5, 2019 through October 17, 2021, at exercise prices of $1.31 and $31.15. With respect to Non-Statutory Options granted to employees, directors or consultants, the Board of Directors or Committee of the Board of Directors may specify such period for exercise that the option shall automatically terminate following the termination of employment or services as to shares covered by the option as the Board of Directors or Committee of the Board of Directors deems reasonable and appropriate. A summary of the Company’s stock option activity and related information follows: September 30, 2018 Weighted Number of average exercise Options price Outstanding, beginning of period 3,697,495 $ 1.51 Granted - - Exercised - - Forfeited/Expired (88,352 ) $ 0.91 Outstanding, end of period 3,609,143 $ 1.31 Exercisable at the end of the period 2,685,690 $ 1.03 Weighted average fair value of options granted during the period $ - The weighted average remaining contractual life of options outstanding issued under the Plan as of September 30, 2018 was as follows: Weighted Average Stock Stock Remaining Exercisable Options Options Contractual Prices Outstanding Exercisable Life (years) $ 6.65 18,571 18,571 6.02 $ 31.15 9,143 9,143 3.84 - 3.92 $ 1.31 3,581,429 2,657,976 2.02 – 2.50 3,609,143 2,685,690 Stock-based compensation expense recognized during the year is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the nine months ended September 30, 2018 and 2017 were $38,361 and $71,603, respectively. Restricted Stock to CEO On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGA are performance based shares and none have yet vested nor have any been issued. The RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the Employees provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “August RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the August RSGA are performance based shares and none have yet vested nor have any been issued. The August RSGA provides for the issuance of up to 1,714,286 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 16, 2018, the Company entered into a Restricted Stock Grant Agreement (the “May RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGA are performance based shares and none have yet vested nor have any been issued. The May RSGA provides for the issuance of up to 30,000,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On September 28, 2018, the Company entered into a Restricted Stock Grant Agreement (the “September RSGA”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the September RSGA are performance based shares and none have yet vested nor have any been issued. The September RSGA provides for the issuance of up to 30,000,000 shares of the Company’s common stock to the CEO provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), Restricted Stock to Employees and Consultants On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “First Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the First Employee RSGA are performance based shares and none have yet vested nor have any been issued. The First Employee RSGA provides for the issuance of up to 857,143 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 12, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Second Employee RSGA”) with an employee, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Employee RSGA are performance based shares and none have yet vested nor have any been issued. The Second Employee RSGA provides for the issuance of up to 571,429 shares of the Company’s common stock to the employee provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 10, 2016, the Company entered into a Restricted Stock Grant Agreement (the “Consultants RSGA”) with two of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Consultants RSGA provides to each of the consultants the issuance of up to 285,714 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On November 10, 2017, the Company entered into a Restricted Stock Grant Agreement (the “Third Employee RSGA”) with nine of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Second Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Second Consultants RSGA provides to the respective consultants the issuance of an aggregate of 2,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants an aggregate of 1,000,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On May 16, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Employee and Consultant RSGA”) with one of its’ employee and one consultant, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employee and Consultant RSGA are performance based shares and none have yet vested nor have any been issued. The Employee and Consultant RSGA provides to the employee and consultant the issuance of an aggregate of 4,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 2,000,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 9, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Employees and Consultants RSGA”) with two of its’ consultants and two employees, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Employees and Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Employees and Consultants RSGA provides to the employees and consultants the issuance of an aggregate of 8,500,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 4,250,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On September 28, 2018, the Company entered into a Restricted Stock Grant Agreement (the “Sep 2018 Consultants RSGA”) with two of its’ consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the Sep 2018 Consultants RSGA are performance based shares and none have yet vested nor have any been issued. The Sep 2018 Consultants RSGA provides to the consultants the issuance of an aggregate of 27,000,000 shares of the Company’s common stock provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 13,500,000 shares in common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), Warrants As of September 30, 2018, the Company issued no warrants during the period. A summary of the Company’s warrant activity and related information follows for the nine months ended September 30, 2018: September 30, 2018 Weighted Number average of exercise Warrants price Outstanding -beginning of the period 53,562,961 $ 5.40 Granted 244,087,101 - Exercised - - Forfeited (36,500,649 ) $ (0.093 ) Outstanding - end of the period 261,149,413 $ 0.0018 At September 30, 2018, the weighted average remaining contractual life of warrants outstanding: Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.080 10,237,388 10,237,388 0.17 $ 0.012 6,824,924 6,824,924 0.67 $ 0.250 244,087,101 244,087,101 2.87 261,149,413 261,149,413 At September 30, 2018, the aggregate intrinsic value of the warrants outstanding was $0.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
	Sep. 30, 2018
Revenue from Contracts with Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	7. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the six months ended September 30, 2018 and 2017. Nine Months Ended September 30, 2018 2018 2017 Equipment Contracts $ 2,486,426 $ 1,325,617 Component Sales 1,003,879 896,333 Services Sales 157,956 61,941 Licensing Fees 30,000 11,000 $ 3,678,261 $ 2,294,891 Revenue recognition for other sales arrangements, such as sales for components, service and licensing fees will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the nine months ending September 30, 2018 was $36,761 and for the year ending December 31, 2017 was $88,589. The contract liability for the nine months ending September 30, 2018 was $250,184 and for the year ending December 31, 2017 was $154,048. During the period ended September 30, 2018, Progressive Water Treatment a wholly-owned subsidiary of OriginClear, Inc., acquired a new division, which offers a unique product line of prefabricated water treatment systems. The Company has contracted with Modern Water System to commercialize his inventions.

Financial Assets

Financial Assets	9 Months Ended
	Sep. 30, 2018
Financial Assets [Abstract]
FINANCIAL ASSETS	8. FINANCIAL ASSETS Convertible Note Receivable The Company purchased a 10% convertible note in the amount of $80,000, through a private placement with Water Technologies International, Inc (“WTII”). The Note is convertible into common stock of WTII at a price of 65% of the lowest trading price for the ten (10) trading days immediately prior to the conversion date. The conversion price shall not be lower than a price of $0.0001 per share. As of September 30, 2018, the note included principal of $80,000 plus accrued interest of $2,883. Fair value investment in Securities The Company purchased 10,000,000 shares of WTII stock through a private placement for cash of $100,000. ASU 2016-01 requires equity investments to be measured at fair value with changes in fair value recognized in net income. During the period the Company exchanged the shares for services in the amount of $80,000, and recognized a loss of $20,000 in the statement of operations. During the period ended September 30, 2018, the Company exchanged the shares for services in the amount of $80,000, incurring a loss on investment of $20,000. On May 15, 2018, the Company received 4,000 shares of WTII preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The preferred shares are convertible into 4,000,000 shares of common stock. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of September 30, 2018, the fair value of the preferred shares was $16,400.

Loans Payable

Loans Payable	9 Months Ended
	Sep. 30, 2018
Loans Payable [Abstract]
LOANS PAYABLE	9. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans range from two months to six months. The net balance as of September 30, 2018 was $698,771, the finance cost of $378,775. Promissory Note Payable The Company entered into a promissory note payable on July 18, 2018 for the sum of $75,000. The principal consists of $67,500 plus a $7,500 origination fee. The interest is sixty-nine percent per annum. The first payment of $6,330 is due September 1, 2018, and $4,318 thereafter. The maturity date of the Note is August 1, 2028. The note is personally guaranteed by the Company’s CEO. As of September 30, 2018, the maturities are summarized as follows: Promissory note payable $ 74,995 Less current portion 93 Long term portion $ 74,902 Long term maturities for the next five years are as follows: 2019 $ 181 2020 355 2021 693 2022 1,356 2023 thru 2028 72,317 $ 74,902

Loans Payable - Related Party

Loans Payable - Related Party	9 Months Ended
	Sep. 30, 2018
Loans Payable - Related Party [Abstract]
LOANS PAYABLE - RELATED PARTY	10. LOANS PAYABLE – RELATED PARTY The Company’s CEO loaned the Company $248,870 during the nine months ended September 30, 2018. The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates. The funds were used for operating expenses. Principal payments were made in the amount of $13,626, leaving a balance of $235,243 as of September 30, 2018.

Capital Leases

Capital Leases	9 Months Ended
	Sep. 30, 2018
Capital Leases [Abstract]
CAPITAL LEASES	11. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the nine months ended September 30, 2018. The lease is for a sixty (60) month term, with a purchase option at the end of the lease for $1.00. As of September 30, 2018, the maturities are summarized as follows: Capital lease $ 38,278 Less current portion 9,088 Total long-term liabilities $ 29,190 Long term maturities for the next four years are as follows: Period Ending September 30, 2019 $ 2,272 2020 9,088 2021 9,088 2022 8,742 $ 29,190

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2018
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Operating Lease – Related Party The Company entered into a month-to-month lease agreement with a shareholder of the Company for office space in McKinney, Texas at a base rent of $4,750 per month. Operating Lease – Equipment The Company entered into a five (5) year equipment lease in the amount of $45,440, which was recorded as a capital lease. There are no escalation or renewal options associated with this lease. The lease has a purchase option to buy the equipment at the end of the lease for one dollar ($1). The monthly lease payments are $757 per month. The future minimum lease payments due as September 30, 2018 is $40,551. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	13. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: Between October 3, 2018 and November 8, 2018, holders of convertible promissory notes converted an aggregate principal and interest amount of $307,250 into an aggregate of 492,630,452 shares of the Company’s common stock. Between October 23, 2018 and October 31, 2018, the Company issued to consultants an aggregate of 45,673,913 shares of the Company’s common stock for services. In connection with certain one-time make good agreements, on October 31, 2018, the Company issued an aggregate of 12,413,226 shares of its common stock to certain holders of its common stock. Between October 2, 2018 and November 6, 2018, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 616 of the Company’s Series F preferred stock for an aggregate purchase price of $616,000. In connection with the Series F Certificate of Designation and subscription agreements entered into with investors, between October 2, 2018 and November 6, 2018, the Company issued an aggregate of 168,435,051 shares of its common stock to certain holders of its Series F preferred stock.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Policies)	9 Months Ended
	Sep. 30, 2018
Summary of Significant Accounting Polices [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technology Limited. All material intercompany transactions have been eliminated upon consolidation of these entities.
Loss per Share Calculations	Loss per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company has excluded 3,609,143 stock options, 261,149,413 warrants, convertible debt of $3,494,546 and shares issuable from convertible preferred stock for the nine months ended September 30, 2018, because their impact on the loss per share is anti-dilutive. The Company did include convertible debt of $549,308 in its diluted earnings per share, because their impact on the earnings per share is dilutive. The Company has excluded 3,697,495 of stock options, 474,335 warrants, and the shares issuable from convertible debt of $3,667,068 and shares issuable from convertible preferred stock for the nine months ended September 30, 2018, because their impact on the loss per share is anti-dilutive.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, debt beneficial conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $6,996 as of September 30, 2018 and December 31, 2017, respectively. The net contract receivable balance was $384,937 and $490,441 at September 30, 2018 and December 31, 2017, respectively.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2018, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets and liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of September 30, 2018. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 16,400 $ - $ - $ 16,400 Total Assets measured at fair value $ 16,400 $ - $ - $ 16,400 The following is a reconciliation of the fair value securities for which level 3 inputs were used in determining the approximate fair value: Balance as of May 17, 2018 $ 130,000 Investment exchanged for services (80,000 ) Net realized loss on asset (20,000 ) Net unrealized loss on asset (13,600 ) Balance as of September 30, 2018 $ 16,400 Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 6,158,447 $ - $ - $ 6,158,447 Total liabilities measured at fair value $ 6,158,447 $ - $ - $ 6,158,447 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2018 $ 5,531,183 Fair Value of derivative liabilities issued 566,312 Loss on change in derivative liability 60,952 Balance as of September 30, 2018 $ 6,158,447 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 9/30/2018 Risk free interest rate 2.15% - 2.94% Stock volatility factor 131.0% - 241.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-2, which creates ASC Topic 842, “Leases.” This update increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This guidance is effective for interim and annual reporting periods beginning after December 15, 2018. We are evaluating what impact, if any, the adoption of this guidance will have on our financial condition, results of operations, cash flows or financial disclosures. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company is currently evaluating the impact of the adoption of ASU 2017-12 on the Company’s financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (ASC 606), to clarify the principles of recognizing revenue and create common revenue recognition guidance between U.S. GAAP and International Financial Reporting Standards. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services and is recognized at an amount that reflects the consideration expected to be received in exchange for such goods or services. In addition, ASC 606 requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The ASC is effective for fiscal years beginning after December 15, 2017. The Company has adopted ASC 606 beginning on January 1, 2018. The adoption of ASC 606 did not have a significant impact on the Company’s revenue recognition policies. See Note 7 for additional disclosures in accordance with the new revenue recognition standard. The Company adopted ASU 2016-01, “Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company is currently evaluating the impact of the adoption of ASU 2018-07 on the Company’s financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Tables)	9 Months Ended
	Sep. 30, 2018
Summary of Significant Accounting Polices [Abstract]
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities $ 16,400 $ - $ - $ 16,400 Total Assets measured at fair value $ 16,400 $ - $ - $ 16,400
Schedule of reconciliation of the fair value securities for which level 3 inputs	Balance as of May 17, 2018 $ 130,000 Investment exchanged for services (80,000 ) Net realized loss on asset (20,000 ) Net unrealized loss on asset (13,600 ) Balance as of September 30, 2018 $ 16,400
Schedule of fair value of (liability) financial instruments	Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 6,158,447 $ - $ - $ 6,158,447 Total liabilities measured at fair value $ 6,158,447 $ - $ - $ 6,158,447
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2018 $ 5,531,183 Fair Value of derivative liabilities issued 566,312 Loss on change in derivative liability 60,952 Balance as of September 30, 2018 $ 6,158,447
Schedule of fair market value of derivative liability assumptions	9/30/2018 Risk free interest rate 2.15% - 2.94% Stock volatility factor 131.0% - 241.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	9 Months Ended
	Sep. 30, 2018
Convertible Promissory Notes [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes, net of debt discount $ 3,722,562 Less current portion 968,438 Total long-term liabilities $ 2,754,124
Schedule of maturities of long-term debt	Period Ending September 30, Amount 2020 2,245,000 2021 325,000 2022 - 2023 184,124 $ 2,754,124

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Sep. 30, 2018
Derivative Liabilities [Abstract]
Schedule of fair market value of the derivative liability	9/30/2018 Risk free interest rate 2.15% - 2.94% Stock volatility factor 131.0% - 241.0.0% Weighted average expected option life 3 months - 5 years Expected dividend yield None

Options and Warrants (Tables)

Options and Warrants (Tables)	9 Months Ended
	Sep. 30, 2018
Options and Warrants [Abstract]
Schedule of stock option activity	September 30, 2018 Weighted Number of average exercise Options price Outstanding, beginning of period 3,697,495 $ 1.51 Granted - - Exercised - - Forfeited/Expired (88,352 ) $ 0.91 Outstanding, end of period 3,609,143 $ 1.31 Exercisable at the end of the period 2,685,690 $ 1.03 Weighted average fair value of options granted during the period $ -
Schedule of weighted average remaining contractual life of options outstanding issued plan	Weighted Average Stock Stock Remaining Exercisable Options Options Contractual Prices Outstanding Exercisable Life (years) $ 6.65 18,571 18,571 6.02 $ 31.15 9,143 9,143 3.84 - 3.92 $ 1.31 3,581,429 2,657,976 2.02 – 2.50 3,609,143 2,685,690
Schedule of warrant activity	September 30, 2018 Weighted Number average of exercise Warrants price Outstanding -beginning of the period 53,562,961 $ 5.40 Granted 244,087,101 - Exercised - - Forfeited (36,500,649 ) $ (0.093 ) Outstanding - end of the period 261,149,413 $ 0.0018
Schedule of weighted average remaining contractual life of warrants outstanding	Weighted Average Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.080 10,237,388 10,237,388 0.17 $ 0.012 6,824,924 6,824,924 0.67 $ 0.250 244,087,101 244,087,101 2.87 261,149,413 261,149,413

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2018
Revenue from Contracts with Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Nine Months Ended September 30, 2018 2018 2017 Equipment Contracts $ 2,486,426 $ 1,325,617 Component Sales 1,003,879 896,333 Services Sales 157,956 61,941 Licensing Fees 30,000 11,000 $ 3,678,261 $ 2,294,891

Loans Payable (Tables)

Loans Payable (Tables)	9 Months Ended
	Sep. 30, 2018
Loans Payable [Abstract]
Schedule of loans payable	Promissory note payable $ 74,995 Less current portion 93 Long term portion $ 74,902
Schedule of long term maturities	Long term maturities for the next five years are as follows: 2019 $ 181 2020 355 2021 693 2022 1,356 2023 thru 2028 72,317 $ 74,902

Capital Leases (Tables)

Capital Leases (Tables)	9 Months Ended
	Sep. 30, 2018
Capital Leases [Abstract]
Schedule of maturities	Capital lease $ 38,278 Less current portion 9,088 Total long-term liabilities $ 29,190
Schedule of long term maturities	Period Ending September 30, 2019 $ 2,272 2020 9,088 2021 9,088 2022 8,742 $ 29,190

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details)	Sep. 30, 2018USD ($)
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	$ 16,400
Total Assets measured at fair value	16,400
(Level 1) [Member]
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
(Level 2) [Member]
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities
Total Assets measured at fair value
(Level 3) [Member]
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Investment at fair value-securities	16,400
Total Assets measured at fair value	$ 16,400

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Schedule of Reconciliation of Derivative Asset [Abstract]
Balance as of May 17, 2018
Net unrealized loss on assets	$ 200		(13,600)
Balance as of June 30, 2018	16,400		16,400
(Level 3) [Member]
Schedule of Reconciliation of Derivative Asset [Abstract]
Balance as of May 17, 2018			130,000
Investment exchanged for services			(80,000)
Net realized loss on asset			(20,000)
Net unrealized loss on assets			(13,600)
Balance as of June 30, 2018	$ 16,400		$ 16,400

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details 2) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Schedule of fair value of financial instruments
Derivative Liability	$ 6,158,447	$ 5,531,183
Total liabilities measured at fair value	10,307,086	$ 8,372,450
(Level 1) [Member]
Schedule of fair value of financial instruments
Derivative Liability
Total liabilities measured at fair value
(Level 2) [Member]
Schedule of fair value of financial instruments
Derivative Liability
Total liabilities measured at fair value
(Level 3) [Member]
Schedule of fair value of financial instruments
Derivative Liability	6,158,447
Total liabilities measured at fair value	$ 6,158,447

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details 3) - Level 3 Inputs [Member]	9 Months Ended
	Sep. 30, 2018USD ($)
Schedule of reconciliation of the derivative liability for which level 3 inputs
Balance as of January 1, 2018	$ 5,531,183
Fair Value of derivative liabilities issued	566,312
Loss on change in derivative liability	60,952
Balance as of September 30, 2018	$ 6,158,447

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details 4) - Fair Value of Financial Instruments [Member]	9 Months Ended
	Sep. 30, 2018
Schedule of fair market value of derivative liability assumptions
Expected dividend yield
Minimum [Member]
Schedule of fair market value of derivative liability assumptions
Risk free interest rate	2.15%
Stock volatility factor	131.00%
Weighted average expected option life	3 months
Maximum [Member]
Schedule of fair market value of derivative liability assumptions
Risk free interest rate	2.94%
Stock volatility factor	241.00%
Weighted average expected option life	5 years

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details Textual)	9 Months Ended
	Sep. 30, 2018USD ($)Segmentsshares	Dec. 31, 2017USD ($)
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	549,308
Contract receivable | $	$ 384,937	$ 490,441
Allowance for doubtful accounts | $	$ 6,996	$ 6,996
Number of segment reporting | Segments	1
Convertible debt [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	3,494,546
Convertible debt one [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	3,667,068
Stock options [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	3,609,143
Warrants [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	261,149,413
Stock options one [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	3,697,495
Warrant one [Member]
Summary of Significant Accounting Polices (Textual)
Antidilutive securities excluded from computation of earnings per share	474,335

Capital Stock (Details)

Capital Stock (Details) - USD ($)	Aug. 14, 2018	Apr. 13, 2018	Apr. 11, 2018	Mar. 14, 2017	Oct. 01, 2015	Sep. 30, 2018	Aug. 09, 2018	Jun. 30, 2018	Dec. 31, 2017
Capital Stock (Textual)
Preferred stock, par value						$ 0.0001			$ 0.0001
Series D Preferred stock issued through a private placement						$ 280,000
Preferred stock, shares authorized						550,000,000			550,000,000
Common stock, shares authorized						8,000,000,000			8,000,000,000
Series B preferred stock [Member]
Capital Stock (Textual)
Stock conversion basis, description					Company's common stock on the last three (3) trading days prior to the date of conversion, provided, however, if the Average Closing Price is less than $0.35 per share.
Preferred stock, shares outstanding						3,333			3,333
Preferred stock, shares issued						3,333			3,333
Conversion price					$ 1.05
Series C preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares outstanding						1,000			1,000
Preferred stock, shares issued						1,000			1,000
Preferred stock, par value				$ 0.0001
Purchase price of the Series C preferred stock				$ 0.10
Total purchase price Series C preferred stock, shares				1,000
Series C preferred Stock [Member] | T. Riggs Eckelberry [Member]
Capital Stock (Textual)
Preferred stock, shares issued				1,000
Preferred stock, par value				$ 0.0001
Series D Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares issued								15,805,554
Series D Preferred stock issued through a private placement						$ 280,000
Description of convertible preferred stock terms		The Board adopted resolutions creating a series of shares of convertible preferred stock designated as 0% Series D preferred stock (the "Series D Preferred Stock") with a par value of $0.0001. The shares of Series D Preferred Stock do not have a dividend rate or liquidation preference and do not carry any voting rights. The purchase price shall be $0.02 per unit for an aggregate investment amount of less than $50,000; $0.018 for an aggregate amount of $50,000 or greater, but less than $100,000; $0.016 for an aggregate amount of $100,000 or greater, but less than $250,000; $0.014 for an aggregate amount of $250,000 or greater. At no time may all or a portion of the Series D Preferred Stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion.
Series D Preferred Stock [Member] | Maximum [Member]
Capital Stock (Textual)
Preferred stock, par value						$ 0.016
Series D Preferred Stock [Member] | Minimum [Member]
Capital Stock (Textual)
Preferred stock, par value						$ 0.020
Series E Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares outstanding						2,440,871			2,440,871
Preferred stock, shares issued						2,440,871			2,440,871
Preferred stock, par value	$ 0.0001
Preferred stock, shares authorized	4,000,000
Description of convertible preferred stock terms	The Company filed a Certificate of Designation for its 0% Series E Convertible preferred stock (the "Series E preferred stock") with the Secretary of State of Nevada designating 4,000,000 shares of its authorized preferred stock as Series E preferred stock, accompanied with one hundred (100) warrants each for the purchase of one (1) share of common stock. The shares of Series E preferred stock have a par value of $0.0001 per share. The shares of Series E preferred stock do not have a dividend rate or liquidation preference. Each share of Series E preferred stock is convertible into one share of common stock. The shares of Series E preferred stock do not carry any voting rights. At no time may all or a portion of the Series E preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of September 30, 2018, there were 2,440,871 shares issued and outstanding.
Series F Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares issued	100
Preferred stock, par value	$ 0.0001
Description of convertible preferred stock terms	The Company filed a Certificate of Designation for its Series F Convertible preferred stock (the "Series F preferred stock") with the Secretary of State of Nevada designating $2,000,000 units, with each unit consisting of 100 shares of the Company's Series F preferred stock. The shares of Series F preferred stock have a par value of $0.0001 per share. The shares of Series F preferred stock do not have a liquidation preference. Each share of Series F preferred stock is convertible into one share of common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company may exercise such redemption right by providing a minimum of 5 days written notice of such redemption to the Holders. In the event the Company exercises such redemption right for less than all of the then-outstanding shares of Series F preferred stock, the Company shall redeem the outstanding shares of the Holders of a pro-rata basis. The Series F is mandatorily redeemable on September 1, 2020. At no time may all or a portion of the Series F preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. As of September 30, 2018, the Company accrued dividends in the amount of $1,976, and has 750 shares issued and outstanding.
Accrued dividends	$ 1,976					$ 167,265,906
Series D-1 Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, shares outstanding						28,500,000			28,500,000
Preferred stock, shares issued						28,500,000			28,500,000
Description of convertible preferred stock terms		The Company filed a Certificate of Designation for its Series D-1 Convertible preferred stock (the "Series D-1 preferred stock") with the Secretary of State of Nevada designating 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock have a par value of $0.0001 per share. The shares of Series D-1 preferred stock do not have a dividend rate or liquidation preference. Each share of Series D-1 preferred stock is convertible into one share of common stock. The shares of Series D-1 preferred stock do not carry any voting rights. At no time may all or a portion of the Series D-1 preferred stock be converted if the number of shares of common stock to be issued pursuant to such conversion would exceed, when aggregated with all other shares of common stock owned by the holder at such time, the number of shares of common stock that would result in the holder beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules thereunder) more than 4.99% of all of the common stock outstanding at such time, which amount may be increased to 9.99% at the holders discretion. The Company issued 28,500,000 preferred shares for services. As of September 30, 2018, there were 28,500,000 shares issued and outstanding.
Common Stock [Member]
Capital Stock (Textual)
Common stock for settlement of convertible promissory notes						292,974,292
Aggregate principal amount						$ 524,714
Interest amount						$ 62,668
Common stock issued for services, shares						117,724,284
Common stock issued at fair value for services						$ 994,689
Share exchange agreement, description						One third (1/3) of the shares received by the holder may be converted into common stock beginning one (1) year after the first date on which a share of Series B Preferred Stock was issued (the "Original Issue Date); one third (1/3) may be converted beginning two (2) years after the Original Issue Date; and the remaining one third (1/3) may be converted beginning three years after the Original Issue Date. The number of shares of common stock issuable for each share of converted Series B preferred stock shall be calculated by dividing the stated value by the market price, the market price shall be the average of the closing trade prices of the twenty-five (25) days prior to the date of the conversion notice.
Debt conversion amount						$ 860,880
Common Stock [Member] | Maximum [Member]
Capital Stock (Textual)
Conversion price						$ 0.0329
Common stock, shares authorized							8,000,000,000
Common Stock [Member] | Minimum [Member]
Capital Stock (Textual)
Conversion price						$ 0.0019
Common stock, shares authorized							2,000,000,000
Preferred Stock [Member]
Capital Stock (Textual)
Preferred stock, par value			$ 0.0001
Issuance of common stock, shares						15,805,554
Series D Preferred stock issued through a private placement						$ 1,581
Common stock for settlement of convertible promissory notes
Preferred Stock [Member] | Maximum [Member]
Capital Stock (Textual)
Preferred stock, shares authorized			550,000,000
Preferred Stock [Member] | Minimum [Member]
Capital Stock (Textual)
Preferred stock, shares authorized			750,000
Preferred Stock [Member] | Series D Preferred Stock [Member]
Capital Stock (Textual)
Description of convertible preferred stock terms			The Board adopted a Certificate of Designation establishing the rights, preferences, privileges and other terms of Series D preferred stock and Series D-1 preferred stock, par value $0.0001 per share. The Board authorized and approved 400,000,000 shares of Series D and 50,000,000 shares of Series D-1 preferred stock.

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Short-term Debt [Line Items]
Convertible Promissory Notes, net of debt discount	$ 3,722,562
Less current portion	968,438	$ 766,931
Total long-term liabilities	$ 2,754,124	$ 2,811,000

Convertible Promissory Notes _2

Convertible Promissory Notes (Details 1)	Sep. 30, 2018USD ($)
Maturities of long-term debt
2,020	$ 2,245,000
2,021	325,000
2,022
2,023	184,124
Total	$ 2,754,124

Convertible Promissory Notes _3

Convertible Promissory Notes (Details Textual) - USD ($)	Dec. 22, 2017	Dec. 20, 2017	Feb. 23, 2018	Aug. 28, 2018	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2016
Convertible Promissory Notes (Textual)
Convertible promissory notes					$ 2,754,124	$ 2,811,000
Converted an aggregate principal amount					1,448,262
Derivative liability					6,158,447	$ 5,531,183
Dec 2015 Note [Member]
Convertible Promissory Notes (Textual)
Aggregate remaining amount					$ 167,048
Description of debt instrument					Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note					$ 432,048
Percentage of average of lowest closing prices					75.00%
Number of trading days previous to conversion					25 days
Sep 2016 Note [Member]
Convertible Promissory Notes (Textual)
Recognized interest expense					$ 140,543
Description of debt instrument					Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Conversion of accounts payable into a convertible note					$ 430,896
Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Convertible promissory notes					4,043,854
Remaining debt discount					321,292
Net balance					$ 3,722,562
Debt instrument interest rate					10.00%
Converted an aggregate principal amount					$ 121,600
Number of shares converted into common stock					50,762,187
Aggregate remaining amount					$ 1,364,400		$ 430,896
Accrued interest					$ 44,064
Conversion price per share of debt, description					50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes.
Fair value loss on settlement					$ 328,540
Convertible Promissory Notes [Member] | Maximum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt					$ 4.90
Convertible Promissory Notes [Member] | Minimum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt					$ 2.10
OID Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument, maturity date					Dec. 31, 2017
Aggregate remaining amount					$ 184,124
Accrued interest					$ 13,334
Conversion price of debt					$ 15.31
Conversion price per share of debt, description					After the amendment, the conversion price changed to the lesser of $2.80 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Original issue discount on promissory notes					$ 184,124
Unsecured convertible promissory notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Debt instrument, maturity date					May 19, 2020
Aggregate remaining amount					$ 1,325,000
Conversion price per share of debt, description					50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes.
Unsecured convertible promissory notes [Member] | Maximum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt					$ 2.80
Unsecured convertible promissory notes [Member] | Minimum [Member]
Convertible Promissory Notes (Textual)
Conversion price of debt					$ 0.70
Dec 20 Note [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Debt instrument, maturity date					Dec. 20, 2018
Converted an aggregate principal amount		$ 150,000			$ 123,500
Number of shares converted into common stock					72,963,066
Aggregate remaining amount					$ 26,500
Recognized interest expense					33,603
Accrued interest					$ 8,033
Conversion price per share of debt, description					The Dec 20 Note may be converted into shares of the Company's common stock at a conversion price of the lesser of $0.05 per share or 50% of the lowest trade price during the twenty trading days immediately before the conversion.
Fair value loss on settlement					$ 197,877
Dec 22 Note [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount	$ 75,000				$ 69,864
Number of shares converted into common stock					40,129,653
Aggregate remaining amount					$ 5,136
Recognized interest expense					$ 6,450
Conversion price per share of debt, description					The Dec 22 Note may be converted into shares of the Company's common stock at a conversion price of the lesser of $0.05 per share or 50% of the lowest trade price during the twenty trading days upon default of the prepayment date.
Fair value loss on settlement					$ 80,509
Notes maturity date					Dec. 22, 2018
Jan-Aug 2018 Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount				$ 293,000	$ 174,000
Number of shares converted into common stock					97,506,179
Aggregate remaining amount					$ 119,000
Recognized interest expense					201,834
Accrued interest					$ 8,700
Conversion price per share of debt, description					The Company's common stock at a variable conversion price of 61% of the lowest one (1) trading day during the ten (10) trading days prior to conversion.
Fair value loss on settlement					$ 175,027
Feb 2018 Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Additional notes issuance			$ 78,750
Converted an aggregate principal amount			157,500		$ 35,750
Number of shares converted into common stock					31,613,207
Aggregate remaining amount					$ 121,750
Recognized interest expense					34,065
Accrued interest					$ 1,872
Conversion price per share of debt, description					The second of the two Feb 2018 Notes shall initially be paid for by the issuance of an offsetting $78,750 secured note issued to the Company by the Buyer. The first of the two notes was funded with cash and the Company must agree to the funding of the second of the two Feb 2018 Notes, before it can be funded with cash. The second of the two Feb 2018 Notes is secured by assets of the Buyer having a fair market value of at least $78,750. The second of the Feb 2018 Notes was issued on August 23, 2018 in the amount of $78,750. The second of the Feb 2018 Notes may be converted into shares of the Company's common stock at a conversion price of $0.03 or 50% discount of the lowest trading price during the twenty (20) trading days prior to conversion.
Fair value loss on settlement					$ 78,927
Aggregate principal each amount			$ 78,750
Notes maturity date					Feb. 23, 2019
Apr & May 2018 Notes [Member]
Convertible Promissory Notes (Textual)
Debt instrument interest rate					10.00%
Converted an aggregate principal amount					$ 300,000
Aggregate remaining amount					300,000
Recognized interest expense					$ 67,082
Conversion price per share of debt, description					The Apr & May 2018 Notes may be converted into shares of the Company's common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty five (25) trading days prior to conversion.

Derivative Liabilities (Details

Derivative Liabilities (Details) - Derivative liability [Member]	9 Months Ended
	Sep. 30, 2018
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Expected dividend yield
Minimum [Member]
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Risk free interest rate	2.15%
Stock volatility factor	131.00%
Weighted average expected option life	3 months
Maximum [Member]
Summary of significant assumptions used in the Binomial lattice valuation model for the derivative
Risk free interest rate	2.94%
Stock volatility factor	2.41%
Weighted average expected option life	5 years

Derivative Liabilities (Detai_2

Derivative Liabilities (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Derivative Liabilities (Textual)
Loss on conversion of debt amount	$ 860,880
Fair value of the derivative liability	6,158,447	$ 5,531,183
Fair value of conversion note issuance	566,312
Convertible Promissory Notes [Member]
Derivative Liabilities (Textual)
Fair value of conversion feature notes	524,714
Principal amount of convertible promissory notes	$ 62,668

Options and Warrants (Details)

Options and Warrants (Details) - Stock options [Member]	9 Months Ended
	Sep. 30, 2018$ / sharesshares
Number of Options
Outstanding, beginning of period | shares	3,697,495
Granted | shares
Exercised | shares
Forfeited/Expired | shares	(88,352)
Outstanding, end of period | shares	3,609,143
Exercisable at the end of the period | shares	2,685,690
Weighted average exercise price
Outstanding, beginning of period	$ 1.51
Granted
Exercised
Forfeited/Expired	0.91
Outstanding, end of period	1.31
Exercisable at the end of the period	1.03
Weighted average fair value of options granted during the period

Options and Warrants (Details 1

Options and Warrants (Details 1)	9 Months Ended
	Sep. 30, 2018$ / sharesshares
$31.15 [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices | $ / shares	$ 31.15
Stock Options Outstanding	9,143
Stock Options Exercisable	9,143
Stock Options [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options Outstanding	3,609,143
Stock Options Exercisable	2,685,690
Stock Options [Member] | $6.65 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices | $ / shares	$ 6.65
Stock Options Outstanding	18,571
Stock Options Exercisable	18,571
Weighted Average Remaining Contractual Life (years)	6 years 7 days
Stock Options [Member] | $1.31 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices | $ / shares	$ 1.31
Stock Options Outstanding	3,581,429
Stock Options Exercisable	2,657,976
Stock Options [Member] | $1.31 [Member] | Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 7 days
Stock Options [Member] | $1.31 [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	2 years 6 months
Stock Options [Member] | $31.15 [Member] | Minimum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	3 years 10 months 3 days
Stock Options [Member] | $31.15 [Member] | Maximum [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Weighted Average Remaining Contractual Life (years)	3 years 11 months 1 day

Options and Warrants (Details 2

Options and Warrants (Details 2) - Warrants [Member]	9 Months Ended
	Sep. 30, 2018$ / sharesshares
Number of Warrants
Outstanding - beginning of the period | shares	53,562,961
Granted | shares	244,087,101
Exercised | shares
Forfeited | shares	(36,500,649)
Outstanding - end of the period | shares	261,149,413
Weighted average exercise price
Outstanding - beginning of the period | $ / shares	$ 5.40
Granted | $ / shares
Exercised | $ / shares
Forfeited | $ / shares	(0.093)
Outstanding - end of the period | $ / shares	$ 0.0018

Options and Warrants (Details 3

Options and Warrants (Details 3)	9 Months Ended
	Sep. 30, 2018$ / sharesshares
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Warrants Outstanding	261,149,413
Warrants Exercisable	261,149,413
Warrants [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum | $ / shares	$ 0.250
Weighted Average Remaining Contractual Life (years)	2 years 10 months 14 days
Warrants Outstanding	244,087,101
Warrants Exercisable	244,087,101
Warrants [Member] | 0.08 - 0.12 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum | $ / shares	$ 0.080
Weighted Average Remaining Contractual Life (years)	2 months 1 day
Warrants Outstanding	10,237,388
Warrants Exercisable	10,237,388
Warrants [Member] | 8.75 - 9.10 [Member]
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices, Range Minimum | $ / shares	$ 0.012
Weighted Average Remaining Contractual Life (years)	8 months 2 days
Warrants Outstanding	6,824,924
Warrants Exercisable	6,824,924

Options and Warrants (Details T

Options and Warrants (Details Textual) - USD ($)	Aug. 09, 2018	Nov. 10, 2017	Aug. 10, 2016	May 12, 2016	Sep. 28, 2018	May 16, 2018	Sep. 30, 2018	Sep. 30, 2017
Options and Warrants (Textual)
Common stock shares reserves and sets aside for the granting of options (in shares)							3,614,285
Stock options mature, description							The stock options mature on July 5, 2019 through October 17, 2021, at exercise prices of $1.31 and $31.15.
Stock based compensation							$ 38,362	$ 71,603
Warrants outstanding							$ 0
T. Riggs Eckelberry [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares			1,714,286	1,714,286	30,000,000
Restricted stock grant agreement, description			The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock.	The Company's common stock to the Employees provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 857,143 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 857,143 shares of its common stock.	The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 15,000,000 shares of its common stock.
First Employee [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares				857,143
Restricted stock grant agreement, description				The First Employee RSGA are performance based shares and none have yet vested nor have any been issued. The First Employee RSGA provides for the issuance of up to 857,143 shares of the Company's common stock to the employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 428,571 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 428,571 shares of its common stock.
Second Employee [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares				571,429
Restricted stock grant agreement, description				The employee provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company's quarterly or annual financial statements, the Company will issue up to 285,714 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 285,714 shares of its common stock.
Consultants [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares			285,714
Restricted stock grant agreement, description			The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to each of the consultants up to 142,857 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 142,857 shares to each of the consultants, its common stock.
May RSGA [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares						30,000,000
Restricted stock grant agreement, description						The Company's common stock to the CEO provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to 15,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue up to 15,000,000 shares of its common stock.
Third Employee RSGA [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares		2,000,000
Restricted stock grant agreement, description		The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants an aggregate of 1,000,000 shares of its common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 1,000,000 shares to the respective consultants, its common stock.
Consultant and Employee RSGA [Member] | Restricted Stock Grant Agreement ("RSGA") [Member]
Options and Warrants (Textual)
Issuance of common stock, shares	8,500,000				27,000,000	4,000,000
Restricted stock grant agreement, description	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 4,250,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 4,250,000 shares of its common stock				The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 13,500,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 13,500,000 shares of its common stock	The Company's common stock provided certain milestones are met in certain stages; a) If the Company's consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue to the respective consultants in various amounts an aggregate of 2,000,000 shares in common stock; b) If the Company's consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company's SEC Reports, the Company will issue an aggregate of 2,000,000 shares of its common stock

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue from Contracts with Customers [Abstract]
Equipment Contracts			$ 2,486,426	$ 1,325,617
Component Sales			1,003,879	896,333
Services Sales			157,956	61,941
Licensing Fees			30,000	11,000
Total	$ 1,094,118	$ 1,112,438	$ 3,678,261	$ 2,294,891

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details Textual) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Revenue from Contracts with Customers (Textual)
Contract assets	$ 36,761	$ 88,589
Contract liability	$ 250,184	$ 154,048

Financial Assets (Details)

Financial Assets (Details) - USD ($)	May 15, 2018	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Financial Assets (Textual)
Stock purchased				10,000,000
Stock purchased for cash				$ 100,000
Recognized loss		$ 200		(13,600)
Shares exchange for service amount				994,689
Financial asset, description	The Company received 4,000 shares of WTII preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The preferred shares are convertible into 4,000,000 shares of common stock. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor's activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of September 30, 2018, the fair value of the preferred shares was $16,400.
Preferred shares fair value		$ 16,400		$ 16,400
10% Convertible Note [Member]
Financial Assets (Textual)
Convertible note percentage		10.00%		10.00%
Convertible note amount		$ 80,000		$ 80,000
Convertible note price				65.00%
Conversion price per share				$ 0.0001
Convertible note principal amount				$ 80,000
Convertible note accrued interest				$ 2,883

Loans Payable (Details)

Loans Payable (Details)	Sep. 30, 2018USD ($)
Summary of maturities
Promissory note payable	$ 74,995
Less current portion	93
Long term portion	$ 74,902

Loans Payable (Details 1)

Loans Payable (Details 1)	Sep. 30, 2018USD ($)
Summary of long term maturities:
2,019	$ 181
2,020	355
2,021	693
2,022	1,356
2023 thru 2028	72,317
Long term portion	$ 74,902

Loans Payable (Details Textual)

Loans Payable (Details Textual)	9 Months Ended
	Sep. 30, 2018
Short-term Debt [Member]
Loans Payable (Textual)
Description of debt instrument	Short term loans with various lenders for capital expansion secured by the Company's assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. The term of the loans range from two months to six months. The net balance as of September 30, 2018 was $698,771, the finance cost of $378,775.
Promissory Note Payable [Member]
Loans Payable (Textual)
Description of debt instrument	Promissory note payable on July 18, 2018 for the sum of $75,000. The principal consists of $67,500 plus a $7,500 origination fee. The interest is sixty-nine percent per annum. The first payment of $6,330 is due September 1, 2018, and $4,318 thereafter. The maturity date of the Note is August 1, 2028.

Loans Payable-Related Party (De

Loans Payable-Related Party (Details) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Loans Payable-Related Party (Textual)
Loan payable, related party	$ 248,870
Maturity date, description	The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates.
Payments made on related party loans	$ 13,626
Loans payable, related party	$ 235,243

Capital Leases (Details)

Capital Leases (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Capital Leases [Abstract]
Capital lease	$ 38,278
Less current portion	9,088
Total long-term liabilities	$ 29,190

Capital Leases (Details 1)

Capital Leases (Details 1)	Sep. 30, 2018USD ($)
Capital Leases [Abstract]
2,019	$ 2,272
2,020	9,088
2,021	9,088
2,022	8,742
Total	$ 29,190

Capital Leases (Details Textual

Capital Leases (Details Textual)	9 Months Ended
	Sep. 30, 2018$ / shares
Capital Lease (Textual)
Capital lease term	60 months
Lease price	$ 1

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Commitments and Contingencies (Textual)
Warrant reserve	$ 20,000	$ 20,000
Equipment lease term	5 years
Capital lease amount	$ 45,440
Description of operating lease	There are no escalation or renewal options associated with this lease. The lease has a purchase option to buy the equipment at the end of the lease for one dollar ($1). The monthly lease payments are $757 per month.
Future minimum lease payments due	$ 40,551
McKinney [Member]
Commitments and Contingencies (Textual)
Base rent	$ 4,750

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	1 Months Ended
	Nov. 08, 2018	Nov. 06, 2018	Oct. 31, 2018	Oct. 23, 2018
Subsequent Events (Textual)
Aggregate principal and interest amount	$ 307,250
Aggregate shares of common stock	492,630,452		45,673,913	45,673,913
Common Stock [Member]
Subsequent Events (Textual)
Aggregate shares of common stock			12,413,226
Series F Preferred Stock [Member]
Subsequent Events (Textual)
Aggregate shares of common stock		168,435,051
Subsequent event, description		The Company sold an aggregate of 616 of the Company's Series F preferred stock for an aggregate purchase price of $616,000.